Abstract: Disclosed herein are methods, systems and devices to model adaptive immune responses and develop and/or test improved antibodies, vaccines, and other therapeutic agents. The adaptive immune responses can be modeled using lymphoid tissue derived from a subject. The methods, systems and devices disclosed herein can comprise modified T-cells.

Abstract: Compositions and methods are provided for peptide sequences that are ligands for a T cell receptor (TCR) of interest, in a given MHC context.

Abstract: Compositions and methods are provided relating to TLR agonist nanoparticle vaccine adjuvant formulations.

Abstract: Compositions and methods are provided relating to immunostimulatory TLR agonist nanoparticle formulations. Methods are provided for treating cancer, by stimulating an immune response to cancer cells through administering to an individual mammal an effective dose or series of doses of an immunostimulatory composition comprising an immunostimulatory TLR agonist-nanoparticle; optionally in combination with a second immune regulatory agent.

Abstract: Polymeric nanoparticles comprising a defined set of biologically active agents that provide for targeted stimulation of non-responsive T cells, e.g. T cells involved in cancer, are provided.

Abstract: An antigen-specific T cell binding agent is provided, where a multivalent ‘spheromer’ system utilizes a scaffold of a self-assembling polypeptide nanoparticle, for example using selfassembling ferritin polypeptides. The system is compatible with current pMHC reagents, including both MHC-I and MHC-II molecules, and streptavidin reagents that allow ease-of-use. The spheromer assembly pipeline provides a consistent reagent across multiple batches of synthesis with ease of production. The defined geometry of the scaffold allows precise site-directed conjugation of pMHC, leading to a homogenous reagent. The spheromer binds cognate TCRs with a significantly higher avidity than a tetrameric reagent.

Abstract: Disclosed herein are methods, systems and devices to model adaptive immune responses and develop and/or test improved antibodies, vaccines, and other therapeutic agents. The adaptive immune responses can be modeled using lymphoid tissue derived from a subject.

Abstract: Provided herein are methods and compositions for diagnosis and treatment of multiple sclerosis. Compositions and methods are provided, relating to novel peptides involved in autoimmune disease. In the experiments described herein, an unbiased approach was used to screen pathogenic CD4+ T cells from patients with multiple sclerosis (MS), and to determine the antigenic specificity of the T cell receptors (TCR) expressed by these pathogenic cells.

Abstract: A pressure swing adsorption process is provided to remove oxygen from a hydrogen stream through the use of a copper material in combination with layers of adsorbent to remove water, C2 and C3 hydrocarbons, as well as other impurities. The feed gas comprises more than 70 mol % hydrogen, at least 1 mol % methane and more than 10 ppmv oxygen. The purified product hydrogen stream comprises greater than 99 mol % hydrogen, with less than 1 ppmv oxygen.

Abstract: Compositions and methods are provided for isolating, manipulating and using for therapeutic and other purposes, mammalian, MHC Class I restricted, antigen-specific regulatory T cells. The regulatory T cells can be characterized as CD8+ cells that specifically suppress the responses of self-reactive and/or pathogenic CD4+ T cells by cytotoxic mechanisms including, without limitation, perform, other components of the perforin/granzyme apoptosis pathway, etc. The regulatory T cells are antigen-specific, but are not activated by the same antigen as the self-reactive and/or pathogenic CD4+ T cells. In humans the regulatory T cells express inhibitory KIR proteins, e.g. one or more of KIR2DL2, KIR2DL3, and KIR3DL1.

Abstract: A multistage membrane system and a process for treating a gas stream is provided in which the multistage membrane system comprises at least two membrane units wherein a first stage membrane unit comprises a polymeric membrane and a second membrane unit comprises a microporous zeolitic inorganic membrane or a combination of a microporous zeolitic inorganic membrane and a polymeric membrane.

Abstract: A process of treating a natural gas stream is provided comprising sending natural gas stream through a first adsorbent bed to remove water and heavy hydrocarbons (C8+) to produce a partially treated gas stream in which the first adsorbent bed is regenerated by a temperature swing adsorption process and then sending the partially treated gas stream through a second adsorption bed to remove carbon dioxide and lighter hydrocarbons (C7?) to produce a purified natural gas stream wherein said second adsorption bed is regenerated by a temperature pressure swing adsorption process.

Abstract: Provided herein is a method for measuring the levels of chronic inflammaging (SCI) of a subject. In some embodiments, the method may comprise measuring the amount of two or more of the proteins CXCL9, TRAIL, IFNG, EOTAXIN and GROA in a sample (e.g., blood serum) from the subject calculating a score based on the weighted amounts of each of those proteins.

Abstract: A pressure swing adsorption process is provided to remove oxygen from a hydrogen stream through the use of a copper material in combination with layers of adsorbent to remove water, C2 and C3 hydrocarbons, as well as other impurities. The feed gas comprises more than 70 mol % hydrogen, at least 1 mol % methane and more than 10 ppmv oxygen. The purified product hydrogen stream comprises greater than 99 mol % hydrogen, with less than 1 ppmv oxygen.

Abstract: Polymeric nanoparticles comprising a defined set of biologically active agents that provide for targeted stimulation of non-responsive T cells, e.g. T cells involved in cancer, are provided.

Abstract: Compositions and methods are provided for peptide sequences that are ligands for a T cell receptor (TCR) of interest, in a given MHC context.

Abstract: A process of treating a natural gas stream is provided comprising sending natural gas stream through a first adsorbent bed to remove water and heavy hydrocarbons (C8+) to produce a partially treated gas stream in which the first adsorbent bed is regenerated by a temperature swing adsorption process and then sending the partially treated gas stream through a second adsorption bed to remove carbon dioxide and lighter hydrocarbons (C7?) to produce a purified natural gas stream wherein said second adsorption bed is regenerated by a temperature pressure swing adsorption process.

Abstract: A multistage membrane system and a process for treating a gas stream is provided in which the multistage membrane system comprises at least two membrane units wherein a first stage membrane unit comprises a polymeric membrane and a second membrane unit comprises a microporous zeolitic inorganic membrane or a combination of a microporous zeolitic inorganic membrane and a polymeric membrane.

Abstract: Methods and oligonucleotide reagents for analyzing individual T cells are disclosed. In particular, the present disclosure provides methods for analyzing individual T cells using high-throughput multiplex amplification and deep sequencing of nucleic acids encoding T cell receptors (TCRs) and various other T cell phenotypic markers. The present disclosure further provides methods of reconstituting TCRs from individual T cells for functional studies, ligand discovery, or screening therapeutics.

Abstract: Methods are provided to determine the entire genomic region of a particular HLA locus including both intron and exons. The resultant consensus sequences provides linkage information between different exons, and produces the unique sequence from each of the two genes from the individual sample being typed. The sequence information in intron regions along with the exon sequences provides an accurate HLA haplotype.